These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 7920440)
21. Influence of clindamycin on derepression of beta-lactamases in Enterobacter spp. and Pseudomonas aeruginosa. Sanders CC; Sanders WE; Goering RV Antimicrob Agents Chemother; 1983 Jul; 24(1):48-53. PubMed ID: 6414365 [TBL] [Abstract][Full Text] [Related]
22. [Antimicrobial susceptibility and beta-lactamase types among clinical isolates during January and February 2000 in the Kinki area of Japan]. Yamasaki K; Nishio H; Komatsu M; Satoh K; Yamashita T; Washidu R; Shimakawa K; Kinoshita S; Ura T; Aihara M Jpn J Antibiot; 2002 Sep; 55 Suppl A():65-78. PubMed ID: 12599530 [TBL] [Abstract][Full Text] [Related]
23. The emergence of beta-lactam resistance among strains of Enterobacter cloacae and Pseudomonas aeruginosa. Aronoff SC Pediatr Infect Dis J; 1989 Sep; 8(9 Suppl):S100-3; discussion S128-32. PubMed ID: 2510122 [TBL] [Abstract][Full Text] [Related]
24. Beta-lactamase induction and aminoglycoside susceptibility in Pseudomonas aeruginosa. Stratton CW; Weeks LS; Tausk F J Antimicrob Chemother; 1987 Jan; 19(1):21-5. PubMed ID: 3104276 [TBL] [Abstract][Full Text] [Related]
25. [Drug sensitivity and beta-lactamase producibility of various types of bacteria clinically isolated during the period from December 1999 to February 2000]. Hashimoto K; Kinosita C; Yoshinaga H; Sonda Y; Itoyama T; Oyamada K; Kajimura K; Kondou M; Sagawa K; Ouno T; Kawamoto K; Souda K; Hara K; Kakihara M; Tanaka T; Ryutou M; Shichiji A; Nakashima K; Ishibashi K; Tabira R; Yamamoto S; Nishida M; Tsutsumi Y Jpn J Antibiot; 2002 Sep; 55 Suppl A():86-94. PubMed ID: 12599532 [TBL] [Abstract][Full Text] [Related]
26. Three cases of IMP-type metallo-β-lactamase-producing Enterobacter cloacae bloodstream infection in Japan. Hamada Y; Watanabe K; Tada T; Mezaki K; Takeuchi S; Shimizu T; Kirikae T; Ohmagari N J Infect Chemother; 2013 Oct; 19(5):956-8. PubMed ID: 23160627 [TBL] [Abstract][Full Text] [Related]
27. Effect of cefoxitin and clindamycin on selection of derepressed mutants in Enterobacter cloacae. Saverino D; Milintenda-Floriani F; Medeiros AA New Microbiol; 2004 Jul; 27(3):249-53. PubMed ID: 15460527 [TBL] [Abstract][Full Text] [Related]
28. [Antimicrobial susceptibility and beta-lactamase producibility of bacteria clinically isolated during the period from December 1999 to February 2000]. Abe M; Takaichi F; Amano H; Tazawa S; Satoh T; Nishizawa M; Takagi T; Miyamoto T Jpn J Antibiot; 2002 Sep; 55 Suppl A():54-64. PubMed ID: 12599529 [TBL] [Abstract][Full Text] [Related]
29. Ascorbate as an induction inhibitor of beta-lactamase in a strain of Enterobacter cloacae. Shoeb HA; Al-Shora HI; Abdel-Salam T Lett Appl Microbiol; 1995 Dec; 21(6):398-401. PubMed ID: 8554767 [TBL] [Abstract][Full Text] [Related]
30. Influence of beta-lactamase inhibitors on the potency of their companion drug with organisms possessing class I enzymes. Cavalieri SJ; Sanders CC; New C Antimicrob Agents Chemother; 1991 Jul; 35(7):1343-7. PubMed ID: 1929291 [TBL] [Abstract][Full Text] [Related]
31. Combination effect of clindamycin with ceftazidime and cefoperazone in inducing filamentous growth of Enterobacter cloacae and Pseudomonas aeruginosa. Nishihata T; Kunieda S; Mikawa M; Nakahama C; Soejima R J Antibiot (Tokyo); 1994 Jul; 47(7):843-7. PubMed ID: 8071132 [No Abstract] [Full Text] [Related]
32. Characterization of NPS-1, a novel plasmid-mediated beta-lactamase, from two Pseudomonas aeruginosa isolates. Livermore DM; Jones CS Antimicrob Agents Chemother; 1986 Jan; 29(1):99-103. PubMed ID: 3089139 [TBL] [Abstract][Full Text] [Related]
33. SHV-type extended-spectrum beta-lactamase production is associated with Reduced cefepime susceptibility in Enterobacter cloacae. Szabó D; Bonomo RA; Silveira F; Pasculle AW; Baxter C; Linden PK; Hujer AM; Hujer KM; Deeley K; Paterson DL J Clin Microbiol; 2005 Oct; 43(10):5058-64. PubMed ID: 16207962 [TBL] [Abstract][Full Text] [Related]
34. Selection and properties of Pseudomonas aeruginosa variants resistant to beta-lactam antibiotics. Cullman W; Büscher KH; Dick W Eur J Clin Microbiol; 1987 Aug; 6(4):467-73. PubMed ID: 3117536 [TBL] [Abstract][Full Text] [Related]
35. Further identification of CTX-M-2 extended-spectrum beta-lactamase in Pseudomonas aeruginosa. Picão RC; Poirel L; Gales AC; Nordmann P Antimicrob Agents Chemother; 2009 May; 53(5):2225-6. PubMed ID: 19223647 [No Abstract] [Full Text] [Related]
36. The cefoperazone-sulbactam combination. In vitro qualities including beta-lactamase stability, antimicrobial activity, and interpretive criteria for disk diffusion tests. Jones RN; Barry AL; Thornsberry C; Wilson HW Am J Clin Pathol; 1985 Oct; 84(4):496-504. PubMed ID: 2994461 [TBL] [Abstract][Full Text] [Related]
37. Resistance caused by decreased penetration of beta-lactam antibiotics into Enterobacter cloacae. Bush K; Tanaka SK; Bonner DP; Sykes RB Antimicrob Agents Chemother; 1985 Apr; 27(4):555-60. PubMed ID: 3873900 [TBL] [Abstract][Full Text] [Related]
38. Activity of cefpirome (HR810) against Pseudomonas aeruginosa strains with characterised resistance mechanisms to beta-lactam antibiotics. Gargalianos P; Oppenheim BA; Skepastianos P; Livermore DM; Williams RJ J Antimicrob Chemother; 1988 Dec; 22(6):841-8. PubMed ID: 3149631 [TBL] [Abstract][Full Text] [Related]